Summary
Grow2Glow is a rotation program designed for young professionals who want to develop their careers at an accelerated pace within a purposeful environment of Novartis Poland.
About The Role
Key Responsibilities:
- Successful delivery of 4 stand alone projects (6/7 months each) within most relevant business areas (Sales / Marketing, Medical, Value & Access, Digital & Innovation, Business Excellence & Execution)
- Ability to influence Polish organization with innovative & business savvy way of thinking; being bold in experimenting and digitally savvy to solve the problems of the future
Essential Requirements
- Working experience of minimum 2 years, preferably within pharma industry
- Polish and English - advanced (min B2/C1) - a must-have
- Innovative Way of Thinking ability to approach problems and challenges with creativity, open-mindedness, and a willingness to explore new ideas and unconventional solutions
- Learning Agility capacity to adjust and thrive in changing circumstances by embracing new approaches, learning quickly, and flexibly responding to unexpected situations
- Curiosity innate drive to explore, question, and seek knowledge, often leading to new insights, discoveries, and a deeper understanding of the world
- Courage ability to confront and overcome obstacles, take risks, and act in the face of adversity or challenging situations
- Collaborative mindset - ability to collaborate well with a broad group of stakeholders, positioning the success of the team above individual goals
Desired Requirements
- Experience abroad would be desired (internship, volunteering / work or Erasmus etc.)
- Leading groups or projects would be a plus (student organization, university groups, working or internship experience)
Rewards
At Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen.
Expected Annual Base Salary Range For Role
- Poland: PLN 101,300 – 188,100
The salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically.
The rewards of being part of our team go far beyond base pay and incentives. We also offer a variety of competitive benefits in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs. In addition, we provide flexible and hybrid working options, where possible, and minimum 14 weeks paid parental leave.
Pay equity is a fundamental principle of our employment policy and reflects our commitment to create a diverse, equitable and inclusive environment that treats all employees with dignity and respect, as outlined in our Code of Ethics.
Read our brochure to learn more about our global total rewards offering: https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf
Note: Benefits and compensation may vary by country and are subject to local legal requirements, including provisions of collective bargaining agreements where applicable. A full overview of your compensation package, including any relevant collective bargaining agreement details applicable to your role based on your employment location and Novartis employer entity, will be communicated separately to you during the application process.
Commitment To Diversity And Inclusion / EEO Paragraph
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Benefits and Rewards: Learn about all the ways we’ll help you thrive personally and professionally.
Read our handbook (PDF 30 MB)